MicroRNA Market, By Technology (Microarray, Real Time PCR, Next Generation Sequencing, and Others), By Application (Cardiovascular disease, Cancer, Neurological disease, Infectious disease, Immunological disorder, and Others), By End-Users (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI501222 | Publish Date: February 2024 | No. of Pages: 170

MicroRNA Market Overview

MicroRNA Market was valued at US$ 991.2 Billion in 2024 and is projected to grow at a CAGR of 10.20%to reach US$ 2397.2Billion by 2034.

MicroRNA (miRNA) is the type of RNA which is found in blood and cells. MicroRNA are smaller than other types of RNA. MicroRNA is a form of small, 18-25 nucleotides long, single stranded RNA, transcribed from DNA and regulates the functions of other genes in protein synthesis. MicroRNA are the genes which modulate other protein coding genes. MicroRNA function by base pairing with target mRNA to negatively regulate its expression. MicroRNA has wide variety of applications. They are small, highly conserved non-coding RNA molecules which are involved in regulation of expression of gene. MicroRNA are transcribed by RNA polymerase II & III. MicroRNA precursors are determined by site of origin of MicroRNA. MicroRNA regulatory function are accomplished through RISC (RNA-induced silencing complex). P-bodies are essential for MicroRNA mediated gene silencing. MicroRNA binds to messenger RNA to block them from making proteins. MicroRNA are used in treatment of cancer. MicroRNA helps in regulating response related to innate and acquired immunity of humans. MicroRNA regulate the transcription, and dysregulation of inflammation related mediators. MicroRNA are found in mostly eukaryotes which includes humans. MicroRNA account for 1-5% of human genome and regulate about 30% of protein coding genes. There are different classes of small endogenous RNA molecules like ribosomal RNA, small transfer RNA, small nucleolar RNA, microRNA, small interfering RNA. MicroRNA and small interfering RNA are functionally and biochemically indistinguishable. MicroRNA precursors are found in clusters by many different regions of genome and most frequently within intergenic regions & introns of protein coding genes. These regions were referred as junk DNA due to its unknown function. Intronic MicroRNA are located within host gene. However, rising prevalence of cancer and other chronic diseases has enhanced the target market growth.

MicroRNA Market Dynamics

Rising prevalence of cancer disease and rate of urbanization is one of the leading factors for the MicroRNA Market growth. MicroRNA act as a potential biomarker for detecting various diseases like cancer, heart disease, infectious disease, etc. MicroRNA helps in diagnosis, prognosis, and treating of cancer diseases. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, alcohol, caffeine, which are unhealthy and affect the health of human being. Urbanization has given rise in disposable income which allows the individual to enhance their lifestyle, spending less on cereals, millets, fruits, vegetables, spending more on processed foods and beverages, consuming high amount of red meat and animal derived food, fats & oils, sugar, sodium, which has affected the health. Unhealthy lifestyle like Smoking, alcohol intake, low fruits and vegetable consumption, lack of exercise, low energy consumption, consumption of fat rich diet, high intake of animal derived food like red meat, smoking, alcohol intake, obesity has given rise in cancer diseases. For instance, in June 2016, difference in lung cancer mortality between city and rural areas were observed in Madrid region and the study determined that most urbanized areas of Madrid region were characterized by higher lung cancer mortality rate. Smoking prevalence from 1985 to 2000 was very high in urban areas and thus it was increased with rapid urbanization. Urbanization has caused unhealthy lifestyle, change in diet, obesity, lack of exercise, pollution, late marriages fewer children, no breast feeding or lesser feeding for less duration, early menarche, late menopause, which has become major contribution in global rise of breast cancer According to ‘The World Cancer Report 2020’ it was determined that incidence of breast cancer is consistently rising in India due to high socio-economic status and rapid urbanization. For instance, in 2016, (NIH), the relationship between cancer incidence and urbanization in Iran were conducted by using Quantile Regression. Data obtained by Ministry of Health & Medical Education and relationship between urbanization and cancer morbidity was investigated by quantile regression and determined that breast cancers, pancreas, prostate, colorectal and lung cancers increasing with rate of urbanization. 90th percentile was maximum increase rate of breast cancer. 95th percentile was of prostate cancer, 75th percentile was of colorectal cancer, 95th percentile for lung cancer and 10th percentile for pancreas cancer. According to the results, it was determined that there was significant impact of rising urbanization on cancer morbidity due to risk factors like more pollution in urban areas, poor nutrition food, lack of exercise, smoking, alcohol intake, etc. However, rising prevalence of cancer disease and growth in urban population has boost the MicroRNA market growth.

 Restrains:

However, occurrence of similar MicroRNAs in various diseases influence the other uncontrollable factors like smoking, circadian cycles, etc. which makes difficult for understanding circulatory MicroRNAs that are specific to particular diseases. Vast disagreeable reports speculates doubt in specificity of MicroRNAs.  Analytical variables in MicroRNA detection cause lack in reproducibility among studies and source of MicroRNAs in circulation is unclear which may somewhat restrain the target market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

MicroRNA Market Segmentation

The MicroRNA market is segmented based on technology, application, end-users and region.

On the basis of technology, the MicroRNA market is segmented into microarray, real time PCR, next generation sequencing, and others.  On the basis of application, the target market is segmented into cardiovascular disease, cancer, neurological disease, infectious disease, Immunological disorder, and others. On the basis of end-users, the target market is segmented into pharmaceutical & biotechnology companies, research institutes, and others.

Regional Insights:

On region the MicroRNA Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of chronic disease, well developed & robust healthcare and research infrastructure, increase in geriatric population, advanced technological development, and government initiative is anticipated to increase demand for MicroRNA in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2024

Forecast period

2024 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 to 2034

Market Segmentation

By Technology - Microarray, Real Time PCR, Next Generation Sequencing, and others

By Application – Cardiovascular disease, Cancer, Neurological disease, Infectious disease, Immunological disorder, and others

By End-Users - Pharmaceutical & Biotechnology Companies, Research Institutes and others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the MicroRNA Market report based on technology, application, end-users, and region:

MicroRNA Market, By Technology:

MicroRNA Market, By Application:

  • Cardiovascular disease
  • Cancer
  • Neurological disease
  • Infectious disease
  • Immunological disorder
  • Others

MicroRNA Market, By End-Users:

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

MicroRNA Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

MicroRNA Market Key Players

The key players operating the MicroRNA Market includes, Thermo Fisher Scientific, Illumina, QIAGEN, NEB, Takara Bio, Agilent Technologies, NanoString Technologies Inc., Bio-Rad Laboratories, Roche, GeneCopoeia, and others.

MicroRNA Market Key Issues Addressed

Recent Development:

  • In November 2018, Credora Life Sciences, India sponsored by The Oxford Dental College, Hospital & Research Center, Bangalore, India has formed the case group where patient with and without OSMF (Oral Sub Mucous Fibrosis) were participated & hence in this study EMT markers in OSMF was accessed, the markers were miRNA-21 – which helps in regulating proliferation of cell, epithelial to mesenchymal transition, and apoptosis during neoplastic progression was up regulated in various cancers. Increased expression of miRNA-21 was seen in myofibroblasts 12. Thus, salivary expression of miRNA-21 was included as a marker.

MicroRNA Market Company Profile

  • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina
  • QIAGEN
  • NEB
  • Takara Bio
  • Agilent Technologies
  • NanoString Technologies Inc.
  • Bio-Rad Laboratories
  • Roche
  • GeneCopoeia

 “*” marked represents similar segmentation in other categories in the respective section

MicroRNA Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. MicroRNA Market, By Technology
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Microarray
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Real time PCR
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Next generation sequencing
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  6. MicroRNA Market, By Application, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Cardiovascular disease
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Neurological disease
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Infectious disease
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Immunological disorder
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032

 

  1. MicroRNA Market, By End-Users, 2022 – 2032, (US$ Bn)
    • Overview                                      
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Pharmaceutical & Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Research Institutes
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  2. MicroRNA Market, By Region, 2022 – 2032, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032

 

        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • QIAGEN
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • NEB
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Takara Bio
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • NanoString Technologies Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roche
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GeneCopoeia
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The MicroRNA Market is segmented into technology, application, end-users, and region.

MicroRNA Market is driven by factors like rising prevalence of cancer diseases & rate of urbanization.

By region, the MicroRNA market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.

The key players operating the MicroRNA Market includes, Thermo Fisher Scientific, Illumina, QIAGEN, NEB, Takara Bio, Agilent Technologies, NanoString Technologies Inc., Bio-Rad Laboratories, Roche, GeneCopoeia, and others.